Brigatinib in crizotinib-refractory ALK+ non-small cell lung cancer (NSCLC): efficacy updates and exploratory analysis of target lesion response by baseline brain lesion status in the ALTA Trial. (January 2019)

Record Type:
Journal Article
Title:
Brigatinib in crizotinib-refractory ALK+ non-small cell lung cancer (NSCLC): efficacy updates and exploratory analysis of target lesion response by baseline brain lesion status in the ALTA Trial. (January 2019)
Main Title:
Brigatinib in crizotinib-refractory ALK+ non-small cell lung cancer (NSCLC): efficacy updates and exploratory analysis of target lesion response by baseline brain lesion status in the ALTA Trial
Authors:
Kim, D.
Huber, R.
Ahn, M.
Langer, C.
Tiseo, M.
West, H.
Groen, H.
Reckamp, K.
Hochmair, M.
Leighl, N.
Hansen, K.H.
Gettinger, S.
Paz-Ares Rodriguez, L.
Kim, E.
Smit, E.
Kim, S.
Reichmann, W.
Kerstein, D.
Camidge, D.R.
Abstract:
Is Part Of:
Lung cancer. Volume 127(2019)Supplement 1
Journal:
Lung cancer
Issue:
Volume 127(2019)Supplement 1
Issue Display:
Volume 127, Issue 1 (2019)
Year:
2019
Volume:
127
Issue:
1
Issue Sort Value:
2019-0127-0001-0000
Page Start:
S30
Page End:
S31
Publication Date:
2019-01
Subjects:
Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424
Journal URLs:
http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0169-5002(19)30120-5 ↗
Languages:
English
ISSNs:
0169-5002
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
9599.xml